Medicine for treating bird flu in humans

Abstract

The invention relates to a pharmaceutical composition for treating bird flu in humans as well as a preparation method and pharmaceutical application of the composition. The medicine comprises 10-100 parts of radix bupleuri, 10-100 parts of fructus forsythiae, 10-100 parts of burdock, 10-100 parts of rhizoma phragmitis, 10-100 parts of mango leaves, 10-100 parts of radix helicteris, 5-50 parts of cordate houttuynia, 5-50 parts of agastache rugosus, 5-50 parts of mangnolia officinalis, 10-60 parts of fried almond, 10-60 parts of scutellaria baicalensis, 10-60 parts of thunberg fritillary bulb, 10-60 parts of semen lepidii, 10-60 parts of root of common peony, 10-60 parts of daphniphyllum calycillum benth, 5-30 parts of ginseng, 5-30 parts of radix ophiopogonis and 5-30 parts of pulp of dogwood fruit. The medicine disclosed by the invention has the following beneficial effects: raw materials are natural Chinese herbal medicines, no toxic and side effect on a human body is caused, and a comprehensive treatment is realized according to the etiology and pathogenesis characteristics of the bird flu in humans, so as to fundamentally treat the bird flu disease; and the medicine is accurate in curative effect and low in cost and has a better treatment effect on the bird flu.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating human infection with avian influenza, a preparation method and pharmaceutical use thereof. Background technique [0002] Human infection with bird flu (Avian Influenza) is a human disease caused by bird flu virus. Avian influenza virus, which belongs to type A influenza virus, is divided into three levels of high, medium, low / non-pathogenicity according to the pathogenicity of avian influenza virus to chickens and turkeys; due to the hemagglutinin structure of avian influenza virus Generally, it infects poultry. When the virus undergoes gene reassortment during the replication process, resulting in structural changes and the ability to infect humans, it may cause human infection with avian influenza. So far, it has been discovered that avian influenza viruses that can directly infect humans The subtypes include: H5N1, H7N1, H7N2, H7N3, H7N...

AI Technical Summary

Problems solved by technology

[0005] So far, vaccination is the basic means of treating viral diseases, but at present there is no vaccine against human infection with avian influenza virus in my country, and even if a vaccine is produced, the virus antigen is easily changed, and after some people are vaccinated, The immune response ability of the bird flu is poor, so it cannot produce the expected effect. At the same time, the development and production cycle of the vaccine is long, which often lags behind the speed of virus mutation. treat

Images